Medicare Part D Insulin Cost: The $35 Monthly Cap and What It Covers

The $35 Cap: What It Actually Covers

Under the Inflation Reduction Act, Medicare Part D plans must cap insulin cost-sharing at the lesser of three amounts:

• $35 per month per covered insulin product
• 25% of the negotiated price
• 25% of the Maximum Fair Price (for insulins subject to Medicare price negotiation)

In practice, most insulin copays land at $35 or below. This cap applies during every phase of the Part D benefit — including the deductible phase. Your parent doesn't need to meet the $615 deductible first. Insulin is carved out from the standard deductible requirement.

The cap applies per insulin product per month, not per total insulin cost. If your parent takes two different insulin products (say, a long-acting basal insulin and a rapid-acting mealtime insulin), each one caps at $35 — so the maximum monthly insulin cost would be $70.

Which Insulins Qualify

The $35 cap covers all Part D-covered insulin products, regardless of:

• Formulation (vial, pen, cartridge)
• Type (rapid-acting, short-acting, intermediate, long-acting, premixed)
• Brand vs. biosimilar

The key qualifier: the insulin must be on your parent's plan's formulary. If the plan doesn't cover a specific insulin product, the $35 cap doesn't apply because the plan isn't covering it at all. Before assuming the cap is in effect, check the formulary during plan comparison.

How the Cap Interacts with the Benefit Phases

The deductible exemption is the most important piece. Without it, a parent on a high-cost insulin could owe hundreds during January and February before the deductible is met. The IRA specifically exempts insulin from the deductible, so the $35 cap applies from the first fill of the year.

What Your Parent's Insulin Payment Counts Toward

The $35 copay your parent pays counts toward their True Out-of-Pocket (TrOOP) spending. This means insulin payments help your parent reach the $2,100 annual cap, after which all covered drugs — including insulin — cost $0.

For a parent taking only insulin and inexpensive generics, reaching the $2,100 cap through $35 monthly copays alone would take roughly 60 months — far longer than a single plan year. The cap is most relevant for parents who also take other high-cost medications.

What to Do If the Pharmacy Charges More Than $35

If the pharmacist rings up insulin for more than $35, something has gone wrong in the claims processing. Common causes:

1. The pharmacy is out-of-network. The $35 cap only applies at in-network pharmacies. Check your parent's pharmacy network status.
2. The insulin isn't on the plan's formulary. Verify formulary coverage.
3. A claims processing error. Ask the pharmacist to reprocess the claim. If the issue persists, call the plan's member services number.

Your parent should never pay the standard coinsurance rate for covered, in-network insulin. The $35 cap is a legal requirement, not a plan-level benefit.

Vaccines Are Also $0

While reviewing your parent's drug costs, note that all ACIP-recommended vaccines (shingles, pneumonia, COVID-19, flu, Tdap, hepatitis B) are covered at $0 under Part D — exempt from both the deductible and cost-sharing. These aren't subject to the $35 cap because there's nothing to cap: the cost is already zero.

Our Medicare Part D guide includes a medication cost tracker that calculates your parent's projected annual insulin spending and shows how it interacts with other drug costs to reach the out-of-pocket cap.

See more United States guides →